Atlanta Consulting Group Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Atlanta Consulting Group Advisors's ELV Position: Q1 2026 in Review
Atlanta Consulting Group Advisors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 931 shares — an estimated $326K sold.
Atlanta Consulting Group Advisors first reported a position in ELV in Q4 2025 and held it in 1 quarter. The position peaked at $326K in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Atlanta Consulting Group Advisors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Atlanta Consulting Group Advisors sold 931 Elevance Health shares in Q1 2026, an estimated $326K.
- Atlanta Consulting Group Advisors first reported a position in Elevance Health in Q4 2025 and held it in 1 quarter.
- Atlanta Consulting Group Advisors's Elevance Health position peaked at $326K in Q4 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Atlanta Consulting Group Advisors's 13F filing for Q1 2026, filed 15 May 2026.